Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many female patients aged between 40 and 60 received prescriptions for hormone replacement therapy in each of the last three years; and how many prescriptions were made to women of those ages in each of the last three years.
Answered by Edward Argar
The following table shows the number of identified female patients aged 40 to 60 years old prescribed hormone replacement therapy (HRT) medication and the number of prescription items for HRT medication where a patient could be identified in each of the last three years.
| Number of identified patients | Number of prescription items for which a patient could be identified |
December 2018 to November 2019 | 661,990 | 2,181,328 |
December 2019 to November 2020 | 614,590 | 2,133,193 |
December 2020 to November 2021 | 782,664 | 2,678,094 |
Source: NHS Business Services Authority
Records of prescriptions written but not dispensed are not held centrally.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many patients received prescriptions for hormone replacement therapy prescriptions in each of the last three years; and how many prescriptions for that treatment were made in each of the last three years.
Answered by Edward Argar
The information is not collected in the format requested. However, the following table shows the number of patients for whom a hormone replacement therapy (HRT) medication has been dispensed and the number of prescription items for HRT medication in the last three years.
| Number of identified patients | Total number of prescription items, including those for which no patient could be identified |
December 2018 to November 2019 | 1,145,262 | 3,923,194 |
December 2019 to November 2020 | 1,076,038 | 3,866,793 |
December 2020 to November 2021 | 1,284,488 | 4,542,567 |
Source: NHS Business Services Authority
Notes:
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve survival rates from sudden cardiac arrest; and whether his Department has made an assessment of the potential merits of increasing access to defibrillators by mandating them to be located in out of hospital settings.
Answered by Maria Caulfield
NHS England is working with partners to improve community first response and build defibrillator networks to improve survival from sudden cardiac arrest. A national network of community first responders and defibrillators will save up to 4,000 lives each year by 2028, supported by educating the public on recognising and responding to a cardiac arrest.
No recent assessment of mandating defibrillators in out of hospital settings has been made. The Government has encouraged communities and organisations in England to consider purchasing a defibrillator as part of first-aid equipment, specifically in densely populated areas.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the proportion of women who are experiencing the menopause that were receiving a prescription for hormone replacement therapy in (a) each of the last three years and (b) each month of the last three years.
Answered by Maria Caulfield
No specific estimate has been made. Data is held on the number of hormone replacement therapy prescriptions, but not on the condition for which they have been prescribed.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make it his policy to submit the Sinopharm vaccine to the MHRA and JCVI for consideration as an alternative to currently available vaccines, for those who are unable to receive their first dose of covid-19 vaccine for medical reasons.
Answered by Maria Caulfield
The Department does not submit treatments or medicines to the Medicines and Healthcare products Regulatory Agency (MHRA) or the Joint Committee on Vaccination and Immunisation for authorisation. Vaccine developers must submit the relevant clinical trial data and safety information to the regulator for consideration. Any route to approval of new vaccine treatments will be subject to the developer seeking regulatory approval from the MHRA. As with all other COVID-19 vaccines, the MHRA will ensure a thorough and expedited assessment of this medicine’s safety and efficacy before any authorisation.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many pregnant women tested positive for covid-19 at HMP Styal in the last two years.
Answered by Gillian Keegan
The information requested is not available in the format requested.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support people who wish to be vaccinated against covid-19 but are allergic to ingredients in the covid-19 vaccines available in the UK.
Answered by Maggie Throup
The UK Health Security Agency’s Green Book provides advice for clinicians to assess individuals with a history of allergy who may suffer a reaction to a COVID-19 vaccine. It also sets out how second dose vaccinations may be considered for those who experienced a reaction to the first. The advice has been developed with the British Society for Allergy and Clinical Immunology (BSACI).
The guidance states that anyone with a history of allergic reaction to an ingredient in a COVID-19 vaccine should not receive it except on expert advice. Those with any other allergies, including those with prior anaphylaxis, may receive the vaccine. If an individual has an allergic reaction to a first dose of vaccine, the BSACI has advised that they may be able to receive a second dose of vaccine. Many individuals have tolerated subsequent doses of the same vaccine and this is preferred as it avoids being incorrectly labelled as allergic for life. Individuals with non-allergic reactions to the first dose of a COVID-19 vaccine can receive the second dose of vaccine in any vaccination setting.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when Public Health England will publish its report into Gambling Related Harms.
Answered by Jo Churchill
Public Health England is carrying out an evidence review on gambling related harms. The evidence review has been delayed due to COVID-19 and is expected to be completed later in summer 2021.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what clinical assessment has been made of the effectiveness of financial controls, such as gambling transaction blocks offered by some banks, in supporting recovery for people experiencing gambling related harm as part of their treatment pathway structures.
Answered by Jo Churchill
No clinical assessment has been made.
The National Health Service has committed to establish up to 15 specialist gambling clinics across England by 2024 and Public Health England will publish the first ever comprehensive evidence review of gambling-related harms later this summer.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the arrangements for the commissioning of clinical treatment for gambling disorders in proposals for a new Health and Care Bill.
Answered by Jo Churchill
No such assessment has been made.